US 8030488
Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
granted A61KA61K31/00A61K31/501
Quick answer
US patent 8030488 (Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/00, A61K31/501, A61K31/551, A61P